Ahava – Dead Sea Laboratories - Israel
Alcyomics Limited - Germany
Agenolab GmbH - Germany
Beiersdorf AG - Germany
BioDetectionSystems b.v. - The Netherlands
BioMed-zet Life Science GmbH - Austria
Biopredic - France
BioTeSys GmbH - Germany
British Amarican Tobacco - United Kingdom
BSL Bioservice - Germany
Cardam - Begium
CeeTox - U.S.A.
CellSystems GmbH - Germany
CIT - France
Cyprotex / Apredica - United Kingdom / U.S.A.
Epithelix - Switzerland
Evocutis plc - United Kingdom
Fraunhofer Institute - Germany
Gaiker - Spain
Harlan Laboratories Ltd.- United Kingdom
Henkel - Germany
Huntingdon Life Sciences Ltd.- United Kingdom
IIVS – Institute for In Vitro Sciences- U.S.A.
InSphero AG- Switzerland
Kallistem Sas - France
KaLy-Cell - France
Kirkstall Ltd. - United Kingdom
Leitat - Spain
LeoPharma - Denmark
L'Oréal - France
MB Research Labs- U.S.A.
Medicyte GmbH - Germany
Natura - France/Brazil
Novozymes A/S - Denmark
Novo Nordisk A/S - Denmark
Philip Morris Products SA - Switzerland
ProteoSys AG- Germany
Reinnervate- United Kingdom
Scantox - Denmark
Thor Personal Care SAS - France
TNO - The Netherlands
Tridskin - Brazil
Vitrocell Systems GmbH - Germany
Permanent Observers:
European Commission
Research Institute of Toxicology (RITOX), dr. Bas Blaauboer
For more information contact:
IVTIP Secretariat
P.O. Box 70
4797 ZH Willemstad NB
The Netherlands
Tel (+31) 654 757 261
Email: ivtip@planet.nl
Web: www.ivtip.org
Our members represent companies in the following sectors: chemicals, cosmetics, consumer products and pharmaceuticals.
Step 1:
As potential member, you should express your interest in joining the IVTIP association by a ‘letter of intent’ addressed to the IVTIP Chairman and Board, and submitted to the IVTIP secretariat (ivtip@planet.nl).
This letter should briefly describe your activities in the area of the 3Rs, how you plan to contribute to the IVTIP mission of replacing animal experimentation for product assessment, and your expectations and anticipated benefits of IVTIP membership.
You are asked to nominate in that letter a representative as contact person for IVTIP.
Step 2:
On receipt of the ‘letter of intent’, your representative will be invited by the IVTIP Board to attend the next appropriate IVTIP business meeting as an observer and to present your case to the IVTIP plenum.
Step 3:
A formal acceptance or rejection (with justification) as an Associated Member will be sent by e-mail within one month after the business meeting.
The Associated Membership will be active once the membership fee has been paid. Benefits of an Associated Member include unrestricted access to the IVTIP internal web site and participation in IVTIP meetings.
Step 4:
After one year as an Associated Member your fulfillment with IVTIP aim and key activities will be evaluated by the IVTIP members, as indicated below. Formal acceptance as a Full Member will be formalized during the appropriate IVTIP business meeting.
The Full Membership will be active once the membership fee has been paid. Benefits of being a Full Member include unrestricted access to the IVTIP internal web site, participation at IVTIP meetings and gives you the right to vote or run as candidate for Board Member or President.
You also acquire the right to use the IVTIP logo on your web site and on communications related to the 3Rs.
C.E.C.,DG Research
Dr. Juergen Buesing, European Commission
With the advent of genomics/proteomics in the compound discovery and development process, many industries report a shortage of qualified and experienced technical and academic personnel. One may contact the companies mentioned above, or check out the following website: Biotech HR Pulse
If you are an SME with activities in the field and would like to be mentioned on this page, please contact the IVTIP secretariat for terms and conditions.